Multipotent describes a stem cell that can produce several different specialized cell types, but only within a related family of cells rather than across the entire body. A blood-forming stem cell in your bone marrow, for instance, can generate red blood cells, white blood cells, and platelets, but it cannot become a brain cell or a skin cell. This restricted-but-still-versatile ability sits in the middle of the stem cell hierarchy, between cells that can become anything and cells locked into producing just one type. Multipotent cells are the workhorses behind everyday tissue repair, and they already underpin some of the most established therapies in medicine.
Where Multipotent Fits in the Potency Hierarchy
Stem cells are ranked by how many different cell types they can generate. At the top sits totipotent, a term reserved for the fertilized egg and the cells of the very early embryo that can form every cell in the body plus the placenta. Below that is pluripotent, which applies to embryonic stem cells and lab-made induced pluripotent stem cells; these can become any cell type within the body but cannot form placental tissue. Multipotent cells sit one rung lower. They self-renew and differentiate into multiple cell types, but they stay within a particular tissue or lineage family.1PubMed Central. Describing the Stem Cell Potency: The Various Methods of Functional Assessment and In silico Diagnostics At the bottom is unipotent, meaning a cell can only make more of one specific type, like certain skin progenitor cells that only produce new skin cells.
The boundaries between these categories are not as crisp as textbook diagrams suggest. Research on blood-forming stem cells, for example, has shown that the old tree-like model with neat branching points is an oversimplification. Instead, lineage commitment appears to happen gradually, with cells shifting their probability of becoming one type versus another as they mature, rather than hitting a single decisive fork in the road.2Immunity. Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential: A Revised Road Map for Adult Blood Lineage Commitment This messiness is worth knowing about, because it means “multipotent” is a useful label but not a rigid law.
Hematopoietic Stem Cells, the Classic Example
The best-known multipotent cell is the hematopoietic stem cell, or HSC, which lives in the bone marrow. HSCs sit at the top of the blood system’s hierarchy, self-renewing throughout your life and progressively giving rise to every type of blood cell.3PubMed Central. New paradigms on hematopoietic stem cell differentiation That includes oxygen-carrying red blood cells, clot-forming platelets, infection-fighting white blood cells of many subtypes, and immune cells like T cells and B cells. A single HSC, transplanted into a mouse, can repopulate all five of these major lineages, and researchers have confirmed that roughly half of individually transplanted HSCs produce both myeloid and lymphoid offspring, meeting the functional definition of multipotency.4Stem Cell Reports. What Is Multipotent? A Definition and Key Examples
HSCs are also the basis for bone marrow transplants, one of the oldest and most successful stem cell therapies. In this procedure, stem cells from a matched donor’s bone marrow, circulating blood, or umbilical cord blood are infused into a patient to rebuild a damaged or diseased blood system.5PubMed Central. Principles and overview of allogeneic hematopoietic stem cell transplantation This treatment can be curative for certain blood cancers, immune deficiencies, and inherited blood disorders. It works precisely because HSCs are multipotent: one population of transplanted cells can regenerate the entire blood and immune system.
Mesenchymal Stem Cells
Mesenchymal stem cells, commonly called MSCs, are another prominent multipotent type. Found in bone marrow, fat tissue, umbilical cord tissue, and other sources, MSCs can differentiate into bone-forming cells, fat cells, and cartilage cells.6Stem Cells. Identification of Common Pathways Mediating Differentiation of Bone Marrow- and Adipose Tissue-Derived Human Mesenchymal Stem Cells into Three Mesenchymal Lineages Because they are relatively easy to isolate and expand in the lab, MSCs have become one of the most-studied cell types in regenerative medicine.7Bioactive Materials. Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering
Beyond their ability to form structural tissues, MSCs have drawn intense interest for their immune-modulating properties. They can dampen overactive immune responses, which makes them candidates for treating autoimmune diseases, graft-versus-host disease after transplants, and chronic inflammatory conditions.8PubMed Central. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential This dual nature, structural versatility combined with immune modulation, is what sets MSCs apart from other multipotent cells and drives much of the current clinical trial activity around them.9PubMed Central. Mesenchymal stem cells and immunomodulation: current status and future prospects
Neural Stem Cells
Your brain and spinal cord also harbor multipotent cells. Neural stem cells can produce the three main cell types of the central nervous system: neurons, which carry electrical signals; astrocytes, which support and protect neurons; and oligodendrocytes, which wrap nerve fibers in insulating myelin.10PubMed Central. Neural stem and progenitor cells in health and disease Which fate a neural stem cell takes depends heavily on the chemical signals it receives from its surroundings.11PubMed Central. Identifying Genes that Affect Differentiation of Human Neural Stem Cells and Myelination of Mature Oligodendrocytes
Neural stem cells are most active during fetal brain development, but small populations persist in specific regions of the adult brain. Their capacity for self-renewal and differentiation raises the possibility of future therapies for neurodegenerative diseases and spinal cord injuries, though translating lab findings into safe, effective treatments has been slow. The adult brain’s environment is far less permissive for new cell production than the developing embryo’s, which is one reason brain repair remains so difficult.
Intestinal Stem Cells
The lining of your gut replaces itself roughly every three to five days, one of the fastest turnover rates of any tissue in the body. This constant renewal is powered by multipotent intestinal stem cells, identified by a marker called Lgr5, that sit at the base of tiny pockets called crypts in the intestinal wall.12PubMed Central. Modulation of stem cell fate in intestinal homeostasis, injury and repair These cells give rise to all the specialized epithelial cell types lining the gut, including absorptive cells, mucus-secreting cells, and hormone-producing cells. Lineage-tracing experiments have confirmed that individual Lgr5-positive cells are genuinely self-renewing and multipotent.13PubMed Central. Wnt signaling, lgr5, and stem cells in the intestine and skin
Intestinal stem cells are a vivid example of why multipotent cells matter for everyday health. Without them, the barrier between your gut contents and your bloodstream would break down within days, leading to infection and organ failure. They also illustrate a broader principle: most of the stem cells keeping you alive right now are multipotent, not pluripotent. Pluripotent cells are crucial in embryonic development and powerful in the lab, but the cells doing the day-to-day maintenance work in adult tissues are overwhelmingly multipotent or unipotent.
What Controls a Multipotent Cell’s Decisions
A multipotent cell does not randomly pick which specialized type to become. Its fate is guided by a combination of external signals from the surrounding tissue, called the niche, and internal programs encoded in the cell’s own gene regulation. Studies across many tissue types have established this dual-control model: the niche provides chemical signals, physical contact with neighboring cells, and structural cues from the tissue scaffold, while the cell’s internal wiring determines how it interprets those signals.14PubMed. Stem cell niche: structure and function
In the bone marrow, for example, HSCs and their immediate offspring live alongside specialized support cells, including certain mesenchymal cells and blood vessel cells, that produce signaling molecules. One study showed that when a key chemical receptor on multipotent progenitors was deleted, the cells failed to position themselves near the right support cells and produced fewer lymphoid progenitors, reducing the output of immune cells. The support cells themselves turned out to be multitaskers, simultaneously maintaining HSCs and sending differentiation signals to their more mature offspring.15Immunity. CXCR4 and IL-7 Receptor Signaling Coordinate to Maintain Multipotent Hematopoietic Progenitors and Lineage-Restricted Precursors in the Bone Marrow
Internal controls matter just as much. Epigenetic marks, the chemical modifications to DNA and its packaging proteins that turn genes on or off without changing the DNA sequence, play a major role in steering neural stem cell fate during brain development.16PubMed. Epigenetic regulation in neural stem cell differentiation In HSCs, researchers have found that accessibility of specific gene-regulatory regions controls whether a cell leans toward making lymphoid cells or platelets, and that a particular family of regulatory proteins is a key switch for that bias. Restoring the activity of one of these proteins in aged HSCs could shift them back toward producing more immune cells.17Trends in Cell Biology. What Is Multipotent? A Definition and Key Examples
What Happens to Multipotent Cells as You Age
Aging takes a measurable toll on multipotent cells. Tissues throughout the body experience a progressive decline in their ability to maintain and repair themselves, and much of this decline traces back to degenerative changes in the resident stem cells, the niches that support them, and the systemic signals circulating in the blood.18PubMed Central. Stem cell aging: mechanisms, regulators and therapeutic opportunities HSCs in older adults, for instance, tend to produce proportionally more myeloid cells (like platelets and certain white blood cells) and fewer lymphoid cells (like the T cells and B cells critical for adaptive immunity). This shift helps explain why older people are more susceptible to infections and respond less robustly to vaccines.
The causes of stem cell aging are layered. DNA damage accumulates over a lifetime. The niche deteriorates, sending weaker or skewed signals. Inflammatory molecules build up in aged tissues, creating a hostile environment. And epigenetic drift gradually alters which genes are accessible, locking cells into narrower fates. Understanding these processes is a major focus of aging research, because reversing even some of the decline in multipotent cell function could in theory improve tissue repair and immune resilience in older adults.
The Plasticity Debate
In the early 2000s, a wave of studies appeared to show that multipotent cells from one tissue could cross into another tissue’s territory, a phenomenon dubbed plasticity or transdifferentiation. Bone marrow cells were reported to become liver cells, brain cells, or heart muscle cells. If true, this would mean multipotent cells were more versatile than anyone thought, potentially rivaling pluripotent cells in their usefulness.
The excitement was real, but so was the backlash. Follow-up studies found that many of the apparent conversions were actually explained by cell fusion, where a bone marrow cell merged with a resident tissue cell and picked up its markers without genuinely converting, or by rare contaminating cells that had been misidentified.19PubMed Central. Stem cell plasticity: from transdifferentiation to macrophage fusion A thorough review at the time concluded that no clear, unequivocal evidence supported true transdifferentiation or dedifferentiation in living mammals.20Cell. What Is Multipotent? A Definition and Key Examples
More recent work has reopened the question, at least partially. Researchers have pushed MSCs to adopt non-mesenchymal fates using specific signaling cocktails, and some of these converted cells appeared stable when transplanted into animals.21PubMed. Signaling Pathways in Trans-differentiation of Mesenchymal Stem Cells: Recent Advances The field has not settled on a consensus. Most researchers accept that multipotent cells have a preferred lineage range defined by their tissue of origin, but that under artificial conditions or extreme stress, the boundaries can sometimes be pushed. Whether that flexibility is therapeutically useful in humans remains an open question.
Multipotent Cells and Cancer
The same properties that make multipotent cells useful for tissue repair, self-renewal and the ability to produce diverse offspring, can become dangerous when they go wrong. Cancer stem cells, a subpopulation found in many tumors, share features with normal stem cells, including the capacity for self-renewal and some degree of multipotency. These cells are thought to drive tumor growth, seed metastases, and survive conventional treatments, contributing to relapse.22PubMed Central. Intricate relationship between cancer stemness, metastasis, and drug resistance
The concept that tumors might arise from stem-like cells is not new. Pathologists in the nineteenth century proposed that cancers could develop from “embryonic remnants” left behind in adult tissue, an idea that anticipated modern cancer stem cell theory by over a century.23PubMed Central. Ambiguous cells: the emergence of the stem cell concept in the nineteenth and twentieth centuries Today, the clinical significance of cancer stem cells is still debated, but their existence has shifted how researchers think about treatment resistance. If a chemotherapy drug kills the bulk of tumor cells but spares the stem-like fraction, the tumor can regrow from those survivors. Therapies that specifically target the stem cell properties within tumors are an active area of drug development.
Multipotent Cells in Tissue Engineering
Beyond traditional transplants, multipotent cells are being used to build tissues from scratch in the lab. In one striking experiment, researchers seeded multipotent cardiovascular progenitor cells, derived from human induced pluripotent stem cells, onto a decellularized mouse heart. The progenitor cells migrated through the scaffold and differentiated in place into heart muscle cells, smooth muscle cells, and the cells lining blood vessels. After twenty days of perfusion culture, the engineered heart constructs contracted spontaneously and responded to drugs.24Nature Communications. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells
Lab-grown blood is another frontier. Researchers have developed systems to generate blood-forming progenitor cells from induced pluripotent stem cells in three-dimensional structures that mimic the yolk sac, the organ that produces the first blood cells in an embryo. These progenitors could be matured into red blood cells, macrophages, and functional T cells, including antigen-specific T cells that could recognize a melanoma target.25Cell Reports Methods. Scalable production of definitive hematopoietic progenitor cells from human induced pluripotent stem cells in yolk sac-like organoids The ability to produce multipotent blood progenitors at scale could eventually address shortages in blood transfusion supply and enable personalized immune cell therapies.
An Evolutionary Perspective on Multipotency
Multipotency is not a recent evolutionary invention. A study that profiled the gene activity of stem cells in sponges, some of the earliest-branching animals on Earth, found that the core genetic toolkit of animal stem cells is ancient. Most of the genes active in sponge stem cells predate the origin of animals themselves. Among the relatively few innovations that appeared with multicellular animals were components of a system that protects stem cell genomes from instability.26PubMed Central. The ancestral gene repertoire of animal stem cells
One unexpected finding from this work was that the ancestral stem cell program relies heavily on RNA-based regulation rather than the transcription factor networks that dominate later in development. Many of the RNA-binding proteins identified in sponge stem cells are the same ones that turn out to be critical regulators of mammalian embryonic stem cells. This suggests that the molecular logic of keeping a cell in a flexible, undifferentiated state is deeply conserved, and that the various flavors of multipotent cells found across the animal kingdom are variations on a theme that was set very early in evolutionary history.
How Scientists Prove a Cell Is Truly Multipotent
Claiming a cell is multipotent requires more than showing it can sit in a dish and express certain surface markers. The gold standard is a functional assay: you isolate a single cell, transplant it or let it form a colony, and then check what types of mature cells its offspring become. For HSCs, this means transplanting one cell into a mouse and looking for evidence of both myeloid and lymphoid lineages in the recipient’s blood. In one set of such experiments, about half of individually transplanted HSCs generated both myeloid and lymphoid cells, confirming multipotency at the single-cell level. A closely related but more restricted progenitor population also showed substantial versatility, with over forty percent of single cells producing offspring of both major branches.4Stem Cell Reports. What Is Multipotent? A Definition and Key Examples
Colony-forming assays offer an independent check. Cells are injected and allowed to seed colonies in the spleen, and each colony, derived from a single cell, is analyzed for the presence of different blood lineages. When HSC-derived colonies were examined this way, close to half contained all four lineage types that the assay could detect. These demanding, single-cell-resolution tests are what separate a well-characterized multipotent population from one that merely looks multipotent based on bulk culture experiments, where a mixed starting population could fake the appearance of versatility.
Ethical and Funding Advantages Over Pluripotent Sources
One practical reason multipotent cells get so much clinical attention is that they sidestep the ethical controversies that have dogged embryonic stem cell research. Multipotent cells are harvested from adult tissues or from birth-associated sources like umbilical cord blood. No embryo is created or destroyed in the process, which means fewer regulatory hurdles and broader access to government funding in many countries.27PubMed Central. Alternative sources of pluripotent stem cells: ethical and scientific issues revisited Induced pluripotent stem cells, made by reprogramming adult cells, also avoid the embryo issue, and they can be coaxed through a multipotent intermediate stage on their way to producing specific cell types for therapy. The combination of ethical simplicity, established harvesting techniques, and a long clinical track record (bone marrow transplants have been performed since the 1950s) means multipotent cells are, in many practical senses, the most immediately useful class of stem cell in medicine today.